153 related articles for article (PubMed ID: 17314230)
1. Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection.
An DS; Poon B; Ho Tsong Fang R; Weijer K; Blom B; Spits H; Chen IS; Uittenbogaart CH
Clin Vaccine Immunol; 2007 Apr; 14(4):391-6. PubMed ID: 17314230
[TBL] [Abstract][Full Text] [Related]
2. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice.
Baenziger S; Tussiwand R; Schlaepfer E; Mazzucchelli L; Heikenwalder M; Kurrer MO; Behnke S; Frey J; Oxenius A; Joller H; Aguzzi A; Manz MG; Speck RF
Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15951-6. PubMed ID: 17038503
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.
Gorantla S; Sneller H; Walters L; Sharp JG; Pirruccello SJ; West JT; Wood C; Dewhurst S; Gendelman HE; Poluektova L
J Virol; 2007 Mar; 81(6):2700-12. PubMed ID: 17182671
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.
Watanabe S; Terashima K; Ohta S; Horibata S; Yajima M; Shiozawa Y; Dewan MZ; Yu Z; Ito M; Morio T; Shimizu N; Honda M; Yamamoto N
Blood; 2007 Jan; 109(1):212-8. PubMed ID: 16954502
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 infection and pathogenesis in a novel humanized mouse model.
Zhang L; Kovalev GI; Su L
Blood; 2007 Apr; 109(7):2978-81. PubMed ID: 17132723
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
[TBL] [Abstract][Full Text] [Related]
8. Efficient infection, activation, and impairment of pDCs in the BM and peripheral lymphoid organs during early HIV-1 infection in humanized rag2⁻/⁻γ C⁻/⁻ mice in vivo.
Zhang L; Jiang Q; Li G; Jeffrey J; Kovalev GI; Su L
Blood; 2011 Jun; 117(23):6184-92. PubMed ID: 21505190
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rgammanull mice infected with CCR5-tropic HIV-1.
Sato K; Nie C; Misawa N; Tanaka Y; Ito M; Koyanagi Y
Vaccine; 2010 May; 28 Suppl 2():B32-7. PubMed ID: 20510741
[TBL] [Abstract][Full Text] [Related]
10. HIV Replication Is Not Controlled by CD8+ T Cells during the Acute Phase of the Infection in Humanized Mice.
Petit NY; Lambert-Niclot S; Marcelin AG; Garcia S; Marodon G
PLoS One; 2015; 10(9):e0138420. PubMed ID: 26407077
[TBL] [Abstract][Full Text] [Related]
11. BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection.
Lavender KJ; Pang WW; Messer RJ; Duley AK; Race B; Phillips K; Scott D; Peterson KE; Chan CK; Dittmer U; Dudek T; Allen TM; Weissman IL; Hasenkrug KJ
Blood; 2013 Dec; 122(25):4013-20. PubMed ID: 24021673
[TBL] [Abstract][Full Text] [Related]
12. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.
Zhang L; Meissner E; Chen J; Su L
Sci China Life Sci; 2010 Feb; 53(2):195-203. PubMed ID: 20596827
[TBL] [Abstract][Full Text] [Related]
13. SCID-hu mice: a model for studying disseminated HIV infection.
Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HIV-1 infection in the humanized Rag2-/-γc-/- mouse model.
Sanchez FM; Berges BK
Methods Mol Biol; 2013; 1031():215-22. PubMed ID: 23824904
[TBL] [Abstract][Full Text] [Related]
15. RAG2-/- gamma(c)-/- mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus.
Hofer U; Baenziger S; Heikenwalder M; Schlaepfer E; Gehre N; Regenass S; Brunner T; Speck RF
J Virol; 2008 Dec; 82(24):12145-53. PubMed ID: 18842716
[TBL] [Abstract][Full Text] [Related]
16. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.
Nakata H; Maeda K; Miyakawa T; Shibayama S; Matsuo M; Takaoka Y; Ito M; Koyanagi Y; Mitsuya H
J Virol; 2005 Feb; 79(4):2087-96. PubMed ID: 15681411
[TBL] [Abstract][Full Text] [Related]
17. Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.
Barassi C; Soprana E; Pastori C; Longhi R; Buratti E; Lillo F; Marenzi C; Lazzarin A; Siccardi AG; Lopalco L
J Virol; 2005 Jun; 79(11):6848-58. PubMed ID: 15890924
[TBL] [Abstract][Full Text] [Related]
18. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.
Kuruvilla JG; Troyer RM; Devi S; Akkina R
Virology; 2007 Dec; 369(1):143-52. PubMed ID: 17707071
[TBL] [Abstract][Full Text] [Related]
19. Infectious simian/human immunodeficiency virus with human immunodeficiency virus type 1 subtype C from an African isolate: rhesus macaque model.
Ndung'u T; Lu Y; Renjifo B; Touzjian N; Kushner N; Pena-Cruz V; Novitsky VA; Lee TH; Essex M
J Virol; 2001 Dec; 75(23):11417-25. PubMed ID: 11689623
[TBL] [Abstract][Full Text] [Related]
20. Effect of R77Q, R77A and R80A changes in Vpr on HIV-1 replication and CD4 T cell depletion in human lymphoid tissue ex vivo.
Rajan D; Wildum S; Rücker E; Schindler M; Kirchhoff F
AIDS; 2006 Apr; 20(6):831-6. PubMed ID: 16549966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
